A Study to Assess the Effects of Co-Administration of Sitagliptin and Metformin on Incretin Hormone Concentrations.
Phase of Trial: Phase I
Latest Information Update: 17 May 2017
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 24 Sep 2010 Results presented at the 46th Annual Meeting of the European Association for the Study of Diabetes
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 Planned end date changed from 1 Apr 2009 to 1 Jun 2009 as reported by ClinicalTrials.gov.